113 related articles for article (PubMed ID: 11000582)
1. Macrophage-colony stimulating factor inhibits the growth of human ovarian cancer cells in vitro.
Kawakami Y; Nagai N; Ohama K; Zeki K; Yoshida Y; Kuroda E; Yamashita U
Eur J Cancer; 2000 Oct; 36(15):1991-7. PubMed ID: 11000582
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the CSF-1 receptor sensitizes ovarian cancer cells to cisplatin.
Yu R; Jin H; Jin C; Huang X; Lin J; Teng Y
Cell Biochem Funct; 2018 Mar; 36(2):80-87. PubMed ID: 29372560
[TBL] [Abstract][Full Text] [Related]
3. [The effect of macrophage colony stimulating factor on laryngeal cancer Hep-2 cell line].
Ge P; Zhang B; Zhang J; Gao Z; Kong Q; He W
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Mar; 19(6):265-8. PubMed ID: 16013511
[TBL] [Abstract][Full Text] [Related]
4. Expression of c-fms proto-oncogene product by ovarian cancer cell lines with effects of macrophage colony-stimulating factor on proliferation.
Suzuki M; Sekiguchi I; Ohwada M; Sato I; Matsui T; Tanabe T; Hashimoto S; Yamada M
Oncology; 1996; 53(2):99-103. PubMed ID: 8604248
[TBL] [Abstract][Full Text] [Related]
5. A novel human myeloid leukemia cell line, NKM-1, coexpressing granulocyte colony-stimulating factor receptors and macrophage colony-stimulating factor receptors.
Kataoka T; Morishita Y; Ogura M; Morishima Y; Towatari M; Kato Y; Inoue H; Saito H
Cancer Res; 1990 Dec; 50(23):7703-9. PubMed ID: 1701353
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
7. Effects of GM-CSF and M-CSF on tumor progression of lung cancer: roles of MEK1/ERK and AKT/PKB pathways.
Uemura Y; Kobayashi M; Nakata H; Kubota T; Bandobashi K; Saito T; Taguchi H
Int J Mol Med; 2006 Aug; 18(2):365-73. PubMed ID: 16820947
[TBL] [Abstract][Full Text] [Related]
8. In vitro growth effects of colony-stimulating factors in ovarian cancer.
Connor JP; Squatrito RC; Terrell KL; Antisdel BJ; Buller RE
Gynecol Oncol; 1994 Mar; 52(3):347-52. PubMed ID: 7512521
[TBL] [Abstract][Full Text] [Related]
9. Control of vascular smooth-muscle cell growth by macrophage-colony-stimulating factor.
Herembert T; Gogusev J; Zhu DL; Drueke TB; Marche P
Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):123-8. PubMed ID: 9224637
[TBL] [Abstract][Full Text] [Related]
10. Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2.
Vallera DA; Taylor PA; Aukerman SL; Blazar BR
Cancer Res; 1993 Sep; 53(18):4273-80. PubMed ID: 8364923
[TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 modulates colony-stimulating factor-1 receptor binding by murine bone marrow macrophage precursors.
Perkins SL; Teitelbaum SL
Endocrinology; 1991 Jan; 128(1):303-11. PubMed ID: 1824758
[TBL] [Abstract][Full Text] [Related]
12. Expression of M-CSF and its receptor (C-FMS) during factor-independent cell line evolution from hematopoietic progenitor cells cocultivated with gamma irradiated marrow stromal cell lines.
Greenberger JS; Sakakeeny MA; Leif J; Anklesaria P; Pierce JH; Shadduck RK
Leukemia; 1992 Jul; 6(7):626-33. PubMed ID: 1385639
[TBL] [Abstract][Full Text] [Related]
13. Macrophage colony-stimulating factor stimulates growth progression of the G1-phase fraction and induces monocytic differentiation of the G2/M-phase fraction in human myeloid leukemia cells.
Kato H; Adachi K; Suzuki M; Tanimoto M; Saito H
Exp Hematol; 1993 Nov; 21(12):1597-604. PubMed ID: 8405241
[TBL] [Abstract][Full Text] [Related]
14. Macrophage colony-stimulating factor release and receptor expression in bone cells.
Weir EC; Horowitz MC; Baron R; Centrella M; Kacinski BM; Insogna KL
J Bone Miner Res; 1993 Dec; 8(12):1507-18. PubMed ID: 8304053
[TBL] [Abstract][Full Text] [Related]
15. Messenger RNA decay of macrophage colony-stimulating factor in human ovarian carcinomas in vitro.
Chambers SK; Kacinski BM
J Soc Gynecol Investig; 1994; 1(4):310-6. PubMed ID: 9419789
[TBL] [Abstract][Full Text] [Related]
16. Effects of histologic type on levels of macrophage colony-stimulating factor in liquid contents of benign ovarian tumors.
Hayashi M; Shibazaki M; Sohma R; Inaba N
Am J Med Sci; 2006 Oct; 332(4):181-5. PubMed ID: 17031243
[TBL] [Abstract][Full Text] [Related]
17. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma.
Ripley D; Tang XM; Ma C; Chegini N
Gynecol Oncol; 2001 May; 81(2):301-9. PubMed ID: 11330966
[TBL] [Abstract][Full Text] [Related]
18. Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase.
Chambers SK; Wang Y; Gertz RE; Kacinski BM
Cancer Res; 1995 Apr; 55(7):1578-85. PubMed ID: 7882368
[TBL] [Abstract][Full Text] [Related]
19. Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies.
Baiocchi G; Kavanagh JJ; Talpaz M; Wharton JT; Gutterman JU; Kurzrock R
Cancer; 1991 Feb; 67(4):990-6. PubMed ID: 1825026
[TBL] [Abstract][Full Text] [Related]
20. Enhanced ovarian cancer tumorigenesis and metastasis by the macrophage colony-stimulating factor.
Toy EP; Azodi M; Folk NL; Zito CM; Zeiss CJ; Chambers SK
Neoplasia; 2009 Feb; 11(2):136-44. PubMed ID: 19177198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
